Editors’ Picks: October Highlights From the AACR Journals
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...
Author:
Cancer Research Catalyst Staff
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris,...
AACR is a pioneer in the study of racial/ethnic and other disparities in cancer research and care. The 16th...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
In an innovative new initiative to drive progress against cancer, the American Association for Cancer Research (AACR) has announced...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...
Grab a cold drink and escape the midsummer heat with July’s rendition of Editors’ Picks. This month, the editors...
Improved patient outcomes come from new treatments. New treatments stem from successful clinical trials. Clinical trials build on discoveries...